All Comments by Elliott Mufson

  1. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
  2. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study.
  3. Aging and Alzheimer's disease: lessons from the Nun Study.
  4. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles.
  5. Acetylcholine, aging, and Alzheimer's disease.
  6. Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer's disease.
  7. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide.
  8. Possible mechanisms for atrophy of the human hippocampus.
  9. Zinc and Alzheimer's disease: is there a direct link?
  10. Apolipoprotein E and Alzheimer's disease: a review of recent studies.
  11. Risk of Alzheimer's disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota.
  12. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.
  13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
  14. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.
  15. High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture.